11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
申请人:Merck Sharp & Dohme Corp.
公开号:EP1532122B1
公开(公告)日:2011-12-14
US6730690B2
申请人:——
公开号:US6730690B2
公开(公告)日:2004-05-04
US7179802B2
申请人:——
公开号:US7179802B2
公开(公告)日:2007-02-20
[EN] INHIBITION OF 11 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 FOR OCULAR NEUROPROTECTION<br/>[FR] INHIBITION DE LA 11 BÊTA-HYDROXYSTÉROÏDE DÉHYDROGÉNASE DE TYPE 1 POUR UNE NEUROPROTECTION OCULAIRE
申请人:BAUSCH & LOMB
公开号:WO2009073460A2
公开(公告)日:2009-06-11
A composition comprises a material capable of controlling a level of cortisol in an ocular environment for effecting ocular neuroprotection in subjects in risk of developing or worsening an ocular neurodegenerative condition. Such a composition is injected into or implanted in the subject's posterior segment to provide such neuroprotection.